| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |